$8.13
-0.37-4.35%
Ult. Agg.: Oct 8, 6:29 PM
$8.10
-0.40-4.71%
Harvard Bioscience (HBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Harvard Bioscience (HBIO) ha pubblicato l'ultima guidance il agosto 11, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $89.15M - $90.88M per il periodo.
Rispetto alle previsioni precedenti, Harvard Bioscience {{epsDirection}} ha modificato le sue previsioni di fatturato da un intervallo precedente di {{epsPriorRange}}.
Harvard Bioscience ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Harvard Bioscience. 16
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.15 | $-0.03 | $0.30 | $0.10 |
| Actual | $-0.14 | $-0.33 | $0.00 | $0.00 |
| Surprise | +6.67% | -1000.0% | -100.0% | -100.0% |
| Revenue | ||||
| Estimate | $21.4M | $21.2M | $23.1M | $20.0M |
| Actual | $22.7M | $20.8M | $23.7M | $20.6M |
| Surprise | +5.95% | -2.10% | +2.75% | +2.95% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.10 | $0.26 |
| Revenue | ||
| Consensus | $21.8M | $24.5M |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.14 | $-0.15 | 6.67 % |
| Q1 | May 12, 2026 | $-0.33 | $-0.03 | -1000.0 % |
| Q4 | Mar 12, 2026 | $0 | $0.30 | -100.0 % |
| Q3 | Nov 6, 2025 | $0 | $0.10 | -100.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $22.73M | $21.45M | 5.95 % |
| Q1 | May 12, 2026 | $20.76M | $21.20M | -2.10 % |
| Q4 | Mar 12, 2026 | $23.74M | $23.10M | 2.75 % |
| Q3 | Nov 6, 2025 | $20.59M | $20.00M | 2.95 % |